New drug trial offers hope for chronic Meniere's disease sufferers
Disease control
Recruiting now
This study is testing the long-term safety of an investigational drug called SPI-1005 for adults with Meniere's Disease. Researchers want to see if taking the medication for 6 to 12 months is safe and well-tolerated. The trial is enrolling 200 participants who have active symptom…
Phase: PHASE3 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC